Navigation Links
National Reference Laboratory, Warde Medical Laboratory to Showcase at 2013 AACC Clinical Lab Expo
Date:7/24/2013

Ann Arbor, Michigan (PRWEB) July 24, 2013

A premier national reference laboratory, Warde Medical Laboratory will showcase its comprehensive esoteric testing catalog and unique cost saving operational model in Exhibit Booth 1637 during the 2013 American Association for Clinical Chemistry in Houston, Texas.

One of the world’s largest laboratory medicine events, the event takes place at the George R. Brown Convention Center from July 28-August 1, 2013 and brings together leading industry professionals from around the globe to review the latest in scientific and clinical research, diagnostics, and laboratory management. Visit the AACC Clinical Lab Expo website for event information.

A Different Mission – a Different Model

“A different mission guides our business model,” according to Jon Sanford, Business Development Manager. “Warde was formed in 1985 for a particular purpose; to reduce the cost of laboratory testing while continuously improving the quality of healthcare. We do that in two ways. Our esoteric testing menu is designed to complement, not compete with the menus of our client hospitals and we deliberately operate with a lower profit margin.”

Additionally, not-for-profit hospitals have an opportunity to lower their costs even further by converting reference testing from an expense into an asset through a unique new co-tenancy operational model.

To find out how your hospital can lower the cost of reference testing, visit Warde Medical Laboratory in Booth 1637 at the AACC Clinical Lab Expo or us at http://www.wardelab.com.

About Warde Medical Laboratory (http://www.wardelab.com)

Warde Medical Laboratory provides comprehensive reference testing and esoteric molecular and genetic assays to for-profit and not-for-profit hospitals and multi-hospital groups across the United States. Comprehensive toxicology testing services are also available to companies and organizations for workplace drug screening and forensic testing. Warde‘s state-of-the-art-facility is staffed with highly-trained clinical specialists under the leadership of internationally-known pathologists assuring the highest levels of quality and service. Founded in 1985 with a core mission to improve the quality of healthcare, Warde Medical Laboratory deliberately operates on a lower profit margin to reduce the cost of testing. A unique operational model offers not-for-profit hospitals the opportunity to lower their costs even further.

Read the full story at http://www.prweb.com/releases/Warde/MedicalLaboratory/prweb10959138.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. National Stroke Association Teams With Clinical Trial Matching Service CureLauncher
2. Surveyed U.S. Payers Are Significantly More Likely To Reimburse Biosimilars Developed By Multinational Manufacturers Compared With Those Developed By Regional Emerging Market Players
3. Join Cornerstone Plastic Surgery for an Exclusive Evening with Internationally Reknowned New York Trained Plastic Surgeon Frederick A. Coville, MD
4. Proposals Now Being Accepted for the 2014 Pittsburgh Conference Memorial National College Grants (PCMNCG)
5. GeneCell International’s Director of Operations, Jose Cirino, Organizes A Series of Educational Seminars with South Florida's Leading Obstetricians and Gynecologist
6. Cellular Dynamics International Announces Launch of Initial Public Offering
7. New Research from SRI International Points to Biomarker that Could Track Huntingtons Disease Progression
8. Rocky Mountain Biologicals Joins International Serum Industry Association
9. DuPont Sponsors National AgriScience Ambassador Academy
10. Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013
11. RRD International Names J. Scott Tarrant President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , Dec. 7, 2016  Biocom, the association for the ... statement below following passage of 21 st Century Cures ... November 30 by a 392-26 vote and in the Senate ... be attributed to Joe Panetta , president & CEO ... will give hope to millions of patients around the world. ...
(Date:12/7/2016)...  Vyriad Inc. announced today the appointment of ... Directors. "We are delighted to welcome Al ... develop our oncolytic viruses as the next generation of ... , MD, PhD, CEO of Vyriad. "Al and his ... passion for making a difference for cancer patients—their philanthropy ...
(Date:12/7/2016)... BOULDER, Colo. , Dec. 7, 2016  Muse ... genome engineering technologies, today announced that Dr. Kevin ... member of the Board of Directors. ... , who becomes the company,s Chief Science Officer as ... and Executive Director of the BioDesign Center at the ...
(Date:12/7/2016)... -- Regen BioPharma Inc. (OTCQB: RGBPP) In a ... a team of scientists in Guangzhou, China ... expression of NR2F6 in patients with early cervical cancer correlates ... cervical cancer tissue as well as in the normal tissue ... interesting study and the first that I am aware of ...
Breaking Biology Technology:
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we ... of recovery so we need to do it well. Inadequate sleep levels have been ... blood pressure, stroke, diabetes, and even cancer. Maybe now is the best ... that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...
(Date:11/22/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the company ... Life Sciences Awards as "Most Outstanding in eClinical ... year of recognition and growth for MedNet, which has ... iMedNet ™ , MedNet,s flagship ...
Breaking Biology News(10 mins):